Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-31

FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for sertraline hydrochloride from Rising Pharma Holdings, expanding the availability of a generic sertraline product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sertraline hydrochloride (sertraline hydrochloride)

Snippet

SUPPL AP for SERTRALINE HYDROCHLORIDE (SERTRALINE HYDROCHLORIDE)